Cargando…

Targeting melanoma residual disease by USP7

Detalles Bibliográficos
Autores principales: Vishnoi, Monika, Marchetti, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331028/
https://www.ncbi.nlm.nih.gov/pubmed/30680060
http://dx.doi.org/10.18632/oncotarget.26497
_version_ 1783387076740251648
author Vishnoi, Monika
Marchetti, Dario
author_facet Vishnoi, Monika
Marchetti, Dario
author_sort Vishnoi, Monika
collection PubMed
description
format Online
Article
Text
id pubmed-6331028
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-63310282019-01-24 Targeting melanoma residual disease by USP7 Vishnoi, Monika Marchetti, Dario Oncotarget Editorial Impact Journals LLC 2018-12-25 /pmc/articles/PMC6331028/ /pubmed/30680060 http://dx.doi.org/10.18632/oncotarget.26497 Text en Copyright: © 2018 Vishnoi et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Vishnoi, Monika
Marchetti, Dario
Targeting melanoma residual disease by USP7
title Targeting melanoma residual disease by USP7
title_full Targeting melanoma residual disease by USP7
title_fullStr Targeting melanoma residual disease by USP7
title_full_unstemmed Targeting melanoma residual disease by USP7
title_short Targeting melanoma residual disease by USP7
title_sort targeting melanoma residual disease by usp7
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331028/
https://www.ncbi.nlm.nih.gov/pubmed/30680060
http://dx.doi.org/10.18632/oncotarget.26497
work_keys_str_mv AT vishnoimonika targetingmelanomaresidualdiseasebyusp7
AT marchettidario targetingmelanomaresidualdiseasebyusp7